These experiments showed that SAHA treatment of 3-Hit mice can prevent the development of severe cardiac hypertrophy, increased M2-macrophage population, TGFβ secretion, fibroblast activation, and myocardial fibrosis (Figs. 4, 5, and 6). The gene discussed is TGFB1; the disease is cardiac hypertrophy.